|
May 1
|
Axsome Therapeutics Recognizes May as Mental Health Awareness Month
|
|
Apr 30
|
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
|
|
Apr 22
|
15 Most Black States in the US
|
|
Apr 15
|
Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
|
|
Apr 10
|
Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6
|
|
Apr 2
|
Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study
|
|
Apr 2
|
Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM)
|
|
Apr 1
|
Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder
|
|
Mar 27
|
3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
|
|
Mar 26
|
30 Countries with the Lowest Depression Rates
|
|
Mar 26
|
20 Cloudiest Cities in the U.S., Ranked
|
|
Mar 25
|
Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
|
|
Mar 25
|
Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy
|
|
Mar 23
|
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
|
|
Mar 22
|
Axsome Triumphs Over Major Depressive Disorder With Auvelity
|
|
Mar 20
|
Axsome (AXSM) Begins Dosing in Depression Study on Sunosi
|
|
Mar 19
|
Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
|
|
Mar 13
|
11 Oversold NASDAQ Stocks To Buy Right Now
|
|
Mar 5
|
Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference
|
|
Jan 2
|
Investing in Axsome Therapeutics (NASDAQ:AXSM) five years ago would have delivered you a 796% gain
|